AwardJun 12, 2026, 04:02 AM
Autolus Therapeutics Wins 2026 Prix Galien UK Award for Best Biotech Product
AI Summary
Autolus Therapeutics plc announced it has been honored with the 2026 Prix Galien UK Award for Best Biotechnology Product by the Galien Foundation. This prestigious award, often likened to the Nobel Prize in biopharmaceutical research, recognizes excellence in scientific innovation to improve human health. Dr. Martin Pule, Founder and Chief Scientific Officer, highlighted the award as a testament to the company's dedication to translating pioneering research into new treatment options for patients.
Key Highlights
- Autolus Therapeutics received the 2026 Prix Galien UK Award.
- The award recognizes the company for Best Biotechnology Product.
- The Prix Galien is often called the "Nobel Prize in biopharmaceutical research."
- Award winners are selected by a UK Awards Committee of 12 experts.
- Autolus was founded in collaboration with University College London.
Price Impact
More from AUTL